NEU neuren pharmaceuticals limited

Neuren - where to from here ?, page-95

  1. 1,546 Posts.
    lightbulb Created with Sketch. 799
    It's Gemini, I capped the revenues at $3.5 billion to get a reasonable idea of a potential sp following development of four indications (replacing PWS with HIE).

    I assume in such a situation substantial dividends would be paid to shareholders, Neuren could develop multiple indications and be a cash generating behemoth of which its cash would be rotting in the bank. Dividends for decades...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.90
Change
-0.200(1.53%)
Mkt cap ! $1.607B
Open High Low Value Volume
$13.20 $13.36 $12.89 $2.711M 206.7K

Buyers (Bids)

No. Vol. Price($)
8 408 $12.89
 

Sellers (Offers)

Price($) Vol. No.
$12.90 372 11
View Market Depth
Last trade - 13.27pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.